Data / Medical devices / Switzerland / Anteis SA

Anteis SA: FDA-registered device maker in Plan les ouates Geneve, Switzerland, 3 PMA approvals

Anteis SA is registered with the FDA (registration 3007744205) in Plan les ouates Geneve, Switzerland. It lists 1 device type. The FDA files 3 PMA approvals under its listings, the newest dated July 9, 2026. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number

3007744205

Address

Chemin des aulx 12, Plan les ouates Geneve, Switzerland, 1228

Owner or operator

Anteis SA (10029433)

Roles

Manufacturer

First device listed

January 13, 2012

Registered through

2027

Brand names listed

Belotero Balance (+) Lidocaine, Belotero Intense (+) Lidocaine, Belotero Volume (+) Lidocaine

Devices it lists

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

Compare with other makers

• All makers of Implant, Dermal, For Aesthetic Use

Updated October 21, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.